Bradley Douglas, MD
Obstetrics & Gynecology · Boca Raton, FLNPI 1295742369
Payments from drug & device makers
Across 238 payments — averaging $36.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Royal Biologics, Inc.$3K
- Scynexis, Inc.$1K
- AbbVie$1K
- Astellas Pharma US Inc$430
- Therapeuticsmd, Inc.$423
- Mayne Pharma Commercial LLC$363
- plus $2K from 22 others
What the payments were for
- Consulting fees$4,20049%
- Food & beverage$4,25449%
- Education$1752%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Royal Biologics, Inc. | 3 | $3,200 |
| Scynexis, Inc. | 5 | $1,196 |
| AbbVie(2 entities) | 54 | $1,066 |
| Astellas Pharma US Inc | 12 | $430 |
| Therapeuticsmd, Inc. | 11 | $423 |
| Mayne Pharma Commercial LLC | 60 | $363 |
| Pfizer | 17 | $291 |
| Sumitomo Pharma America, Inc. | 10 | $202 |
| AMAG Pharmaceuticals, Inc. | 6 | $199 |
| Hologic Sales And Service, LLC | 5 | $196 |
| Exact Sciences | 8 | $172 |
| Coopersurgical, Inc. | 4 | $137 |
| Bayer | 6 | $135 |
| Avion Pharmaceuticals | 7 | $96 |
| Exeltis, USA Inc. | 5 | $83 |
| Millicent US Inc | 4 | $78 |
| Myovant Sciences Inc. | 4 | $69 |
| Biogen | 3 | $65 |
| Agile Therapeutics, Inc. | 4 | $54 |
| Vertical Pharmaceuticals, LLC | 2 | $42 |
| Davol Inc. | 1 | $22 |
| IBSA Pharma Inc. | 1 | $22 |
| LSI Solutions Inc | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Roche Diagnostics Corporation | 1 | $15 |
| Duchesnay USA Incorporated | 1 | $14 |
| Channel Medsystems, Inc. | 1 | $12 |
| Lupin Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DermMaxx$1,600
- Maxx-Ultra Cord$800
- Amnio Maxx$800
- Derma Maxx$800
- Orilissa$231
- INTRAROSA$119
- ACESSA PROVU SYSTEM$116
How this compares
$8,629 in reported general payments places this provider in the 90th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 25 | $21,906 |
| PremarinEstrogens, Conjugated | 18 | $9,285 |
| ProgesteroneProgesterone, Micronized | 72 | $4,767 |
| Estradiol | 53 | $2,475 |
| ValacyclovirValacyclovir Hcl | 24 | $1,417 |
| Raloxifene Hcl | 15 | $462 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 39 | $414 |
| Alendronate Sodium | 59 | $342 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 25 | $324 |
| Fluconazole | 53 | $284 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 24 | $97 |
| Misoprostol | 15 | $37 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $430 | $21,90625 claims |
| PfizerPremarin | $291 | $9,28518 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,438 obstetrics & gynecology providers in Florida.
Other obstetrics & gynecology in Boca Raton
- Samuel LedermanLake Worth$13.4M
- Richard MyersJacksonville$2.7M
- Guillermo LievanoMiami$2.5M
- Steven McCarusCelebration$2.3M
- Samuel WolfPanama City$2.1M
- Rafael Garcia-OcasioHialeah$2M
- Douglas MoffettLeesburg$1.7M
- Harvey GlasserAventura$1.6M
- Jorge PandoMiami Lakes$1.5M
- Victoria BedellMiami$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.